Latest Insignia Financial (ASX:IFL) News

Speculative growth names and biotech drove the biggest gains this week, while one consumer staple copped the heaviest selling after cutting guidance. Deal flow stayed busy, but investors were even more responsive to hard numbers: profit upgrades, feasibility studies, contract wins and fresh drilling results.

Deal activity and fintech growth set the pace, with Zip surging and Insignia moving closer to leaving the boards. At the same time, regulators kept pressure on insurance deals and several fund managers showed how choppy markets are hitting assets and flows.

Insignia Financial’s $3.3 billion acquisition by CC Capital Partners has cleared its final legal hurdle, with the Federal Court approving the scheme of arrangement and share trading set to suspend imminently. Shareholders on record will receive $4.80 per share when the deal completes later this month.

The Federal Court has approved the acquisition scheme for Insignia Financial by CC Capital Partners, setting the stage for a $4.80 per share cash payout and imminent ASX suspension.

Insignia Financial shareholders met on 13 April 2026 and overwhelmingly backed a $4.80 per share acquisition scheme by CC Capital, valuing the company at about $3.3 billion and offering a near 57% premium to pre-offer prices.

Rare earths, lithium and antimony stocks drove the week, while a handful of capital raisings and profit warnings hit hard. The biggest gains came from drilling wins and deal news. The sharpest falls came where investors faced dilution, weaker earnings or takeover friction.

Banks drove the week as Bendigo, BOQ and Pinnacle led finance stocks higher on deals that promised lower costs, more lending firepower and balance sheet flexibility. Regulatory trouble at Humm and fresh uncertainty around Sequoia showed how quickly confidence can slip when boards and disclosure come into question.

Insignia Financial has received Foreign Investment Review Board approval for its proposed acquisition by Daintree BidCo, clearing a key regulatory hurdle. The scheme now awaits shareholder and court approvals, with the board recommending shareholder support.

Payments and lending names wore the biggest swings as investors reacted to a large placement, a takeover repricing, and a governance brawl. Deal terms, disclosure quality, and access to funding mattered more than “big picture” talk this week.

Insignia Financial has secured a crucial regulatory approval from APRA, advancing the proposed acquisition by Daintree BidCo. The deal now moves closer to a shareholder vote scheduled for mid-April.

Small caps stole the week, led by a big funding deal in gold and two revenue breakouts. Meanwhile, some well-known names slid after profit updates failed to calm nerves on costs and outlooks.

Big swings hit ASX financials this week as profit updates, takeover votes and cost cuts drove fast re-pricing. The winners paid (or promised) cash. The laggards spooked investors with losses, restructures or shaky earnings outlooks.